No One Should Face Cancer Alone.
Let's Work Together So That No One Will.
NeoGenomics is committed to developing the technical and personal touchpoints to help guide patients and providers to the best solutions and achieve results that matter. From connecting community-based providers to cutting-edge cancer diagnostics to aggregating genomic data to help patients find targeted therapies and clinical trials, NeoGenomics is paving the way forward for every cancer patient today while creating a roadmap to improve outcomes tomorrow.
Our multimodal approach to testing and vast community outreach helps us build a solid network of oncology providers as we unite to serve their patients. Those collaborations fuel our database with insights to inspire our biopharma partners to blaze new trails in research, clinical trial design, and drug development. Working together, we can save lives and the most precious commodity for cancer patients—time.
DISCOVER MORE. SEARCH LESS.
The Difference Is In Our Data
Succeed sooner with data-powered solutions
Cross-Community Capture
We collect diagnostic data from diverse communities located throughout the U.S. and access more than 1.9M patient profiles from more than 68K unique providers and 4,400 organizations.
Multimodal Diagnostic Insights
Beyond NGS testing, we offer various genetic, molecular assays (IHC, FISH, Flow Cytometry, Cytogenetics), capturing multiple cancer diagnoses and prognosis stages. With more than 8,000 samples added daily, our diagnostic insights remain actionable and evolving.
Data Details
Our data includes structured EMR entries, free-text interpretations, and whole-slide pathology images. Information on genomic alterations, computational biomarkers, and PD-L1 results are also available.